← All companies

SGMT

Sagimet Biosciences Inc.

SGMT Nasdaq Pharmaceutical Preparations EDGAR ↗

$8.07

+0.07 +0.94%

Key statistics

from XBRL data in SEC filings

Market cap

$263M

Revenue (TTM)

$2.00M

Net income (TTM)

-$43.5M

EPS (TTM)

$-1.35

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$36.6M

Total assets

$108M

Gross margin

—

52-week range

$4.50 – $10.06

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 21, 2026 8-K Director or officer change; Shareholder vote results Jun 12, 2026 8-K Director or officer change Jun 3, 2026 8-K Results of operations (earnings release) May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Entered a material agreement Apr 28, 2026 8-K Regulation FD disclosure Apr 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Apr 27, 2026 8-K Director or officer change; Other events Apr 21, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 11, 2026 8-K Regulation FD disclosure Feb 2, 2026 8-K Regulation FD disclosure; Other events Dec 18, 2025 8-K Other events Dec 17, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Regulation FD disclosure Oct 23, 2025 8-K Changed accountants Aug 22, 2025 8-K Entered a material agreement; Terminated a material agreement Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Director or officer change; Shareholder vote results Jun 10, 2025 8-K Regulation FD disclosure Jun 4, 2025 8-K Results of operations (earnings release); Other events May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Director or officer change Apr 30, 2025 8-K Results of operations (earnings release); Other events Mar 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 12, 2025 8-K Other events Mar 11, 2025 8-K Other events Feb 14, 2025 8-K Other events Jan 2, 2025 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Entered a material agreement Aug 16, 2024 8-K Results of operations (earnings release); Other events Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Director or officer change Aug 1, 2024 8-K Other events Jul 2, 2024 8-K/A Other events Jun 13, 2024 8-K Shareholder vote results; Other events Jun 6, 2024